For investment teams

An independently measured data set on how the public regards listed companies.

Every month GMS asks a representative sample of the buying public the same questions about every company in the Top US 500, Top UK 100 and Top Australian 200. The resulting Social Responsibility Score® and Net Trust Score values are held point in time, never revised once published, and delivered by API, so research, portfolio and risk teams can each test them in their own work. GMS measures every company in the Top US 500, Top UK 100 and Top Australian 200, which together had a market value of about US$70 trillion at the end of July 2026.

Why the data is distinct

A data set your teams cannot source elsewhere, measured consistently every month and delivered ready for your models.

Methodology

The public is asked directly, with the same questions every month.

GMS asks verified members of the public consistent, calibrated questions about every company in each market, and reports a Score and a Clarity value for each one. Nothing in the data is self-reported by the company, and the methodology is versioned and governed by the GMS Institute.

Infrastructure

Each monthly release is frozen at publication and never revised.

Because published values are never restated, the history carries no look-ahead. Data is delivered through the GMS Portal or by REST API, with ticker and ISIN mapped over time and Benchmark Groups on the GICS Sector taxonomy.

Distinctiveness

The data measures something that generic factors do not contain.

In tests on US companies, generic quality, growth and technical factors together explain about 7.5% of the variation in SRS within sectors, and no single factor correlates with it above 0.12. Because the data comes from GMS's own continuous survey, it cannot be rebuilt from public sources.

Breadth of application

One data set can be evaluated by several teams in the same firm.

The same monthly data supports quantitative research, fundamental analysis, portfolio and risk monitoring, and transaction due diligence, so research, portfolio, risk and deal teams can each test it against their own questions.

Where GMS data sits

A view of listed companies that complements the ESG, sentiment and transaction data you already hold.

It is not ESG data

ESG ratings observe the company, mainly from its own disclosures, and score how it manages risk. GMS asks the public, so the measure is not shaped by corporate disclosure, and published values are not revised.

It is not reputation data

Reputation indices measure esteem for well-known companies, usually once a year. GMS measures every company in the index every month, and reports Clarity (how many people can rate the company) separately from Score (what they conclude).

It is not sentiment data

Sentiment is drawn from whoever chose to post, and a growing share of it is machine-generated. GMS data is asked of verified people, including about business-to-business companies that attract little online discussion.

Its nearest neighbours

Brand health trackers such as YouGov BrandIndex and Morning Consult also survey the public about companies, at consumer-brand level. GMS isolates the Social License to Operate, maps it to the listed entity and its ticker, and calibrates it against revenue growth.

Vendor descriptions are our reading of public material. Please tell us if we have described any of them incorrectly.

Use cases by type of investor

A measure of public recognition and trust that adds to the research, portfolio and transaction work your teams already do.

Systematic and quantitative investors

Hedge funds and quantitative investors continuously test new data sets for information that adds to established factors and alternative data. GMS offers point-in-time monthly company scores, rankings and changes in public recognition and trust that can be tested against returns, earnings, risk and existing investment inputs.

Request evaluation access
How teams use it
  • Factor research and stock selection within quantitative portfolio construction
  • Long and short research on relative rankings and score changes
  • Testing incremental value alongside the data sets already licensed
What we can show today
Core, Full and Extended data sets with portal and REST API access, and the internal test results set out below. Incremental predictive power and out-of-sample performance still need testing, which is what an evaluation is for.
Suggested first step
A focused research evaluation with factor controls and realistic costs.
Fundamental and long-only equity managers

Equity managers need to identify changes in a company's prospects before those changes are fully reflected in earnings forecasts and valuations. GMS provides a monthly measure of public recognition and trust, allowing managers to compare companies with their peers and investigate changes that may have implications for future business performance.

See the data sets
How teams use it
  • Stock screening and investment thesis testing
  • Social License risk monitoring across holdings, to identify where recognition or trust is deteriorating
  • Peer comparison within each Benchmark Group
What we can show today
Monthly SRS data from April 2025 and NTS data from January 2026 across the US, UK and Australian universes. Internal investment tests are indicative and are not proof of future outperformance.
Suggested first step
Review five familiar companies against your own research.
Private equity and transaction advisers

Private equity investors spend considerable time and money understanding a target company's financial performance, market position and future growth prospects, yet conventional due diligence may not reveal whether public confidence in the business is strengthening or weakening. GMS provides an independent measure of public recognition and trust that can be used to challenge an investment thesis, identify risks and monitor progress during ownership. Transaction advisers can bring the same evidence to commercial due diligence without developing their own data collection capability.

Enquire about a Quanta Report
How teams use it
  • Transaction due diligence on a target and its competitors
  • Screening listed targets and comparable companies
  • Investment committee challenge, with the difference expressed as revenue growth
What we can show today
Monthly scores, peer rankings and history for listed companies in the three markets, and SRS Quanta Reports on companies in more than 90 countries. Consumer research suggests links between SRS and revenue performance. Private-company coverage and predictive value for private equity returns are not yet established.
Suggested first step
A short diagnostic on a listed target or comparable company.
Asset owners

Asset owners such as superannuation and pension funds appoint external managers to run many of their listed equity mandates, and need a consistent and independent way to see how the companies those managers hold are regarded by the public. GMS provides a monthly measure of public recognition and trust for every company in the Top US 500, Top UK 100 and Top Australian 200, which investment and stewardship teams can use to review each manager's holdings against their Benchmark Groups and to inform their discussions with managers.

Request evaluation access
How teams use it
  • Reviewing the holdings of each external manager against their Benchmark Groups
  • Social License risk monitoring across mandates, to see where recognition or trust is deteriorating
  • Evidence to support questions in manager reviews and stewardship discussions
What we can show today
Monthly company scores, peer rankings and Benchmark Group context for the Top US 500, Top UK 100 and Top Australian 200. Use in manager oversight has not yet been tested with an asset owner.
Suggested first step
Compare one manager's listed equity holdings with their Benchmark Groups.

Data platforms and distributors that want to offer GMS data to their own users can find the Data Partner program on the partners page.

Evidence

What we can show today, and what we are testing next.

We state each result at the strength the evidence supports, and we report every test to evaluators, including those that find no effect.

EstablishedResults that have held in GMS tests within the stated scope.

Link to revenue in consumer categories

A 4-point SRS lead over a competitor aligns with about 1% higher annual revenue growth in Australian food and grocery. The rate varies by category, and the relationship can be modelled for other consumer categories.

Distinct from generic factors

In US tests, quality, growth and technical factors together explain about 7.5% of the variation in SRS within sectors, and no single factor correlates with it above 0.12.

IndicativeResults that point in a consistent direction and carry a known limitation.

Excluding the lowest-scoring companies

Two sets of results are available. In an internal look-back test, excluding the bottom SRS quartile of the top 500 US companies outperformed the S&P 500 by 4.8% a year over three years, although the test applied 2025 scores to the prior three years. On the monthly data GMS has collected since April 2025, the same exclusion was ahead of the US market in each of four completed quarters, by 5.8 points in total, but it trailed the market in the UK and Australia, largely because of sector allocation. A forward test of a sector-neutral version began on 30 October 2026, and we report its results to evaluators as each quarter completes.

Volatility

Companies with low SRS have historically been the more volatile ones, although that relationship is largely explained by their past price volatility.

Testing nextQuestions GMS is testing now, with no result to report yet.

Incremental information

Whether SRS and NTS add information beyond size, value, momentum, quality and news sentiment, tested out of sample.

Persistence and turnover

How long any relationship lasts, and how much trading a portfolio built on the data implies.

Results are research findings for professional audiences, are hypothetical, and are not investment advice. Past relationships between the data and financial performance do not guarantee future results.

How an evaluation works

Test the data on your own models, with up to 120 days of evaluation access at no cost.

  1. Evaluation of up to 60 days

    Your team receives an API key for the Core plan in the markets and Metrics you select, with the full available history, and tests the data against criteria agreed with GMS.

  2. A further 60 days free

    If your team shares its findings by day 60, the evaluation is extended by a further 60 days at no cost.

  3. Continued access by license

    Continued access after the evaluation is by a 12-month license, on a price and decision date agreed with you when the evaluation starts.

The evaluation is governed by the Data Set Evaluation Terms.